Form 4 for BLFS BIOLIFE SOLUTIONS INC
Accepted 2024-03-29 00:00:00 ET · period of report 2024-03-27 · accession 0001628280-24-013830 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-29 | 2024-03-27 | BLFS | Mathew Aby J. | EVP, CSO | S - Sale | $17.99 | -454 | 319.7K | -0.1% | -$8,167 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-27 | S | D | 454 | $17.99 | 319,682 | D | — | — |